TrialAntimicrobial agents and chemotherapy2019

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.

David Tenero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.